Different types of prostanoids can be easily synthesized in the body by using an enzyme named as cylcooxygenase (COX). These prostanoids including prostaglandins, prostacyclin and thromboxane are important biological mediators that play crucial role in the development of pain and inflammation in the body. So it is possible to get relief from pain and inflammation by inhibiting the COX enzyme.
Vitamin C or ascorbic acid does not significantly lower the levels of uric acid in patients with gout according to the latest study published in the American College of Rheumatology (ACR) journal, Arthritis & Rheumatism. During the past studies it was found that vitamin C is beneficial for gout patients.
A new weapon (Simponi (golimumab) injection) has been approved by the U.S. Food and Drug Administration for the treatment of patients suffering from moderate to severe form of ulcerative colitis.
The U.S. Food and Drug Administration has approved a new advanced drug Xofigo (radium Ra 223 dichloride) for the treatment of symptomatic late-stage (metastatic) castration-resistant prostate cancer that has not yet targeted any other organs of the body instead of bones.